MedTrace Logo

TSN2898-201 Safety and Efficacy of TSN2898 in the Treatment of Acne Vulgaris

NCT02796066 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2017-04-26

No results posted yet for this study

Summary

The purpose of this study is to determine the safety and effectiveness of TSN 2898 topical gel in the treatment of moderate to severe acne.

Conditions

  • Acne Vulgaris

Interventions

DRUG

Vehicle

Applied once a day

DRUG

TSN2898

Applied once a day

DRUG

TSN2898

Applied once a day

DRUG

TSN2898

Applied once a day

Sponsors & Collaborators

  • Thesan Pharmaceuticals, Inc.

    lead INDUSTRY

Principal Investigators

  • Howard Welgus, MD · Thesan Pharmaceuticals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • United States
  • Dominican Republic
  • Honduras

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02796066 on ClinicalTrials.gov